Aug 14 (Reuters)-
RaQualia Pharma Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2025 Jun 30, 2024 Dec 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 1.54 1.41 3.89
(+8.9 pct) (+39.1 pct) (+25.1 pct)
Operating loss 190 mln loss 154 mln 118 mln
Recurring loss 291 mln loss 277 mln 73 mln
Net loss 354 mln loss 323 mln loss 71 mln
EPS loss 15.49 yen loss 14.97 yen loss 3.25 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - RaQualia Pharma Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T